The Democrats have expanded the program under the Affordable Care Act. Republicans have proposed cuts in federal funding and work requirements.

Neither party wants to be perceived as threatening Medicare. The Biden administration has taken steps to reduce payment to ...

KarXT — now with the brand name Cobenfy— is expected to be available in October with a list price of about $22,500 annually. The drug represents a new way to treat adults with schizophrenia.

The Phase I/II trials for rare forms of hereditary blindness further confirmed the potential for gene therapy treatments of ...

Employment satisfaction, sleep quality and lack of physical movement were all tied to vitality levels, survey results show.

The FDA approved IntraBio Inc.'s Aqneursa (levacetylleucine) yesterday for the treatment of ultra rare neurodegenerative ...

A study found omitting a course of antibiotic prophylaxis was non-inferior to the routinely administering antibiotics in ...

Novo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not ...

The FDA has already approved Zoryve cream (0.3% and 0.15%) for plaque psoriasis and atopic dermatitis in adults and children ...

Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...

Gilead Sciences is issuing a voluntary recall of one lot of Veklury (remdesivir) for Injection 100 mg/vial because of glass ...

Clinical data suggests an imbalance in vaso-occlusive crises and fatal events that require further assessment, and the company said it will provide updates in the future.